Wright Medical Group
In 2006, Warburg Pincus invested in Tornier N.V. (Tornier), a France-based, leading global orthopedics company focused on extremity implants. Shortly following Warburg Pincus’ investment, the firm helped Tornier assemble a best-in-class management team and partnered with the company to develop a structured R&D organization which accelerated new product development and rollout. Warburg Pincus continued to invest behind Tornier throughout the hold period, doubling the firm’s initial investment as Warburg Pincus supported the company in funding multiple M&A and product in-licensing transactions. With assistance from Warburg Pincus, the company entered and rapidly grew its new sports medicine and orthobiologics businesses. Additionally, Tornier created a single, extremity specialist sales channel which helped the company expand significantly in the U.S. while continuing to scale its European business. In 2011, Tornier executed a successful IPO, having more than doubled its revenues since Warburg Pincus’ initial investment. Warburg Pincus became a shareholder in Wright Medical Group, N.V. (Wright) when Tornier closed its merger with Wright Medical Group, Inc. (a former Warburg Pincus portfolio company) in 2015. In 2016, Warburg Pincus exited the investment through a sale in the public markets.
Website Case Studies Disclaimer
The investments described in the case studies are provided for illustrative purposes only and are not, and do not purport to be, representative of all investments, or all types of investments, previously made by Warburg Pincus, or indicative of the performance of all prior Warburg Pincus investments. The case studies have been selected on the basis of objective criteria that Warburg Pincus believes are representative of the firm’s experience partnering with portfolio company management teams, and of the sectors, stages, strategies and/or geographies in which the firm invests. The information provided in the case studies are not necessarily an indication of future results, and may not be relied up for any purpose. Warburg Pincus’ current or future portfolio companies may differ materially in size, type, performance and other characteristics from the investments presented in the case studies. Further, references in this case study should not be construed as a recommendation or offer to buy or sell any particular security or to make any particular investment.